References
- PanHJiangTChengNLong non-coding RNA BC087858 induces non-T790M mutation acquired resistance to EGFR-TKIs by activating PI3K/AKT and MEK/ERK pathways and EMT in non-small-cell lung cancerOncotarget2016731499484996027409677
- ChapmanAMSunKYRuestowPCowanDMMadlAKLung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokersLung Cancer201610212213427987580
- ShraderMPinoMSBrownGMolecular correlates of gefitinib responsiveness in human bladder cancer cellsMol Cancer Ther20076127728517237287
- LiuMZhouCZhengJCigarette smoking impairs the response of EGFR-TKIs therapy in lung adenocarcinoma patients by promoting EGFR signaling and epithelial-mesenchymal transitionAm J Transl Res20157102026203526692946
- LiDZhangLZhouJChenHCigarette smoke extract exposure induces EGFR-TKI resistance in EGFR-mutated NSCLC via mediating Src activation and EMTLung Cancer201693354226898612
- VuTJinLDattaPKEffect of cigarette smoking on epithelial to mesenchymal transition (EMT) in lung cancerJ Clin Med201654
- WilsonCNicholesKBustosDOvercoming EMT-associated resistance to anti-cancer drugs via Src/FAK pathway inhibitionOncotarget20145177328734125193862
- DuBShimJSTargeting epithelial-mesenchymal transition (EMT) to overcome drug resistance in cancerMolecules2016217
- YinHWangYChenWZhongSLiuZZhaoJDrug-resistant CXCR4-positive cells have the molecular characteristics of EMT in NSCLCGene20165941232927581786
- SinghASettlemanJEMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancerOncogene201029344741475120531305
- ThomsonSBuckEPettiFEpithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibitionCancer Res200565209455946216230409
- BaiXYZhangXCYangSQBlockade of hedgehog signaling synergistically increases sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer cell linesPLoS One2016113e014937026943330
- FrederickBAHelfrichBAColdrenCDEpithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinomaMol Cancer Ther2007661683169117541031
- XuJYangHZhouXWangHGongLTangCBisdemethoxycurcumin suppresses migration and invasion of highly metastatic 95D lung cancer cells by regulating E-cadherin and vimentin expression, and inducing autophagyMol Med Rep20151257603760826459909
- YanYRXieQLiFEpithelial-to-mesenchymal transition is involved in BCNU resistance in human glioma cellsNeuropathology201434212813424112388
- LiuHZhangHWSunXFTamoxifen-resistant breast cancer cells possess cancer stem-like cell propertiesChin Med J (Engl)2013126163030303423981606
- ShresthaEHusseinMASavasJNPoly(ADP-ribose) polymerase 1 represses liver X receptor-mediated ABCA1 expression and cholesterol efflux in macrophagesJ Biol Chem201629121111721118427026705
- ZhangRLiuZLiYWuBLXR agonist regulates the proliferation and apoptosis of human T-Cell acute lymphoblastic leukemia cells via the SOCS3 pathwayInt J Biochem Cell Biol20167818018527422090
- WuYYuDDHuYLXR ligands sensitize EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt activationBiochem Biophys Res Commun2015467490090526471306
- EngelmanJAZejnullahuKMitsudomiTMET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signalingScience200731658271039104317463250
- FischerKRDurransALeeSEpithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistanceNature2015527757947247626560033
- WareKEHinzTKKleczkoEA mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loopOncogenesis20132e3923552882
- FernandoRIHamiltonDHDominguezCDavidJMMcCampbellKKPalenaCIL-8 signaling is involved in resistance of lung carcinoma cells to erlotinibOncotarget2016727420314204427248176
- MaJLZengSZhangYDengGLShenHEpithelial-mesenchymal transition plays a critical role in drug resistance of hepatocellular carcinoma cells to oxaliplatinTumour Biol20163756177618426614432
- WairaguPMParkKHKimJCombined therapeutic potential of nuclear receptors with receptor tyrosine kinase inhibitors in lung cancerBiochem Biophys Res Commun2014447349049524735536
- KimHYooSBSunPAlteration of the E-cadherin/beta-catenin complex is an Independent poor prognostic factor in lung adenocarcinomaKorean J Pathol2013471445123483484